Study examines effectiveness of targeted spraying for malaria control in low-transmission settings

IRS refers to the application of insecticide onto the interior walls of houses.

The study, by the Wits Research Institute for Malaria (WRIM) and the London School of Hygiene and Tropical Medicine (LSHTM), was published in The Lancet on 25 February 2021.

Targeted vs blanket indoor residual spraying

Malaria still represents one of the world's largest health crises, particularly on the African continent where 94% of cases and deaths occur (World Health Organization, 2020).

Most countries in southern Africa have set the elimination of malaria within their borders as a policy target.

In South Africa, IRS has been effectively used since 1945. As a result, malaria transmission is low, but persistent. Malaria transmission is confined to the north-eastern border districts of Mpumalanga, Limpopo, and KwaZulu-Natal provinces.

IRS has been a highly effective strategy for controlling malaria in many countries. However, IRS is logistically challenging when deployed at scale and its costs are rising, due in part to the challenges posed in addressing resistance of malaria vector mosquitoes to low-cost insecticides.

Furthermore, it may be unwarranted and unsustainable to spray all houses in areas where malaria is rare (but not eliminated), particularly when resources are limited.

At a global level, spending on malaria prevention and treatment has remained stagnant for almost a decade, despite rising unit costs and growing populations. More efficient strategies are therefore urgently required to sustain malaria elimination efforts in low transmission settings.

The increase in rural populations makes it very difficult to carry out IRS at the recommended coverage of 85% of all households before the malaria transmission season is in full swing. Reactive spraying and the substantial cost-saving make [targeted IRS] an effective strategy for the national and provincial malaria control programmes to adopt - based on good scientific data."

Maureen Coetzee, Study Co-Author and Distinguished Professor, Wits Research Institute for Malaria

About the study

The study, titled Effectiveness and cost-effectiveness of reactive, targeted indoor residual spraying for malaria control in low-transmission settings: a cluster-randomized, non-inferiority trial in South Africa, was the first to investigate whether reactive, targeted IRS is non-inferior and more cost-effective compared with the standard practice of an annual mass spray campaign ahead of malaria season.

The trial was conducted in residential areas (clusters) in Bushbuckridge, Mpumalanga and in Phalaborwa, Limpopo province.

Clusters were randomly assigned to either the targeted or the standard approach. In the intervention arm of the trial, the teams only sprayed houses in response to a reported malaria case, and restricted spraying to just that house [the index case house] and up to eight neighboring houses within 200m.

The targeted intervention therefore involved a substantial reduction in spraying, directed only at neighborhoods where there had been recent evidence of malaria transmission as indicated by the occurrence of a recent malaria case.

Safe and cost-effective strategies

The findings proved that, within the pre-specified margin of 1 case per 1000 people per year, the targeted approach was no worse than the standard approach. Furthermore, the targeted approach proved highly cost-effective.

The average annual economic cost was $88 258 (±R1.2m, 2017 exchange rate) per 100,000 population for the targeted intervention, which is 52% less costly than the standard practice, which costs $184 319 (±R2.5m, 2017 exchange rate).

"The targeted intervention cost less because it involved spraying far fewer structures, did not use contract sprayers, and used substantially less insecticide, transport, and equipment," says Mr David Bath, Research Fellow in Health Economics at LSHTM and joint first author of the study with Dr Jackie Cook, Associate Professor in Malaria Epidemiology at LSHTM.

Targeted transmission solutions

The authors acknowledge that replacing an existing intervention, which has been standard practice for many years, would be politically and socially sensitive, and would require vigilance to avoid resurgence in cases. It is therefore important that strategies which reduce costs due to better targeting of IRS are based on robust evidence, as demonstrated by this study.

Mr Aaron Mabuza, co-chair of the South African Malaria Elimination Committee (SAMEC), co-author of the study and former manager of the Mpumalanga Provincial Malaria Control Programme, says: "I used to wonder whether there was an alternative to blanket IRS and this study on targeted IRS has addressed my question. The recommendations are realistic and implementable, and also tackle the problem of population increase, which now makes it nearly impossible for blanket IRS to be completed before high transmission starts."

Targeted IRS ensures the reallocation of saved resources to other life-saving malaria control and elimination activities, such as enhanced awareness campaigns, case management, surveillance, and epidemic preparedness

"The findings of the study represent an exciting development to divest funds into other areas contributing to malaria elimination in very low-transmission settings across southern Africa," says Coetzee.

Source:
Journal reference:

Bath, D., et al. (2021) Effectiveness and cost-effectiveness of reactive, targeted indoor residual spraying for malaria control in low-transmission settings: a cluster-randomised, non-inferiority trial in South Africa. Lancet. doi.org/10.1016/S0140-6736(21)00251-8.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
WHO urges equitable action to end malaria burden